More articles from Research letters

Outcomes over the first two years of treatment with mepolizumab in severe asthma
Lynn Elsey, Thomas Pantin, Leanne-Jo Holmes, Gael Tavernier, Stephen J. Fowler

European Respiratory Journal Dec 2021, 58 (6) 2101313; DOI: 10.1183/13993003.01313-2021
Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy
Francesca Saluzzo, Paola Mantegani, Valeria Poletti de Chaurand, Federica Cugnata, Patrizia Rovere-Querini, Marta Cilla, Patrizia Paola Erba, Sara Racca, Cristina Tresoldi, Caterina Uberti-Foppa, Clelia Di Serio, Daniela Maria Cirillo

European Respiratory Journal Dec 2021, 58 (6) 2102099; DOI: 10.1183/13993003.02099-2021
Epigenetic blood biomarkers of ageing and mortality in COPD
Ana I. Hernandez Cordero, Chen Xi Yang, Stephen Milne, Xuan Li, Zsuzsanna Hollander, Virginia Chen, Raymond Ng, Scott J. Tebbutt, Janice M. Leung, Don D. Sin

European Respiratory Journal Dec 2021, 58 (6) 2101890; DOI: 10.1183/13993003.01890-2021
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease
Scott M. Matson, Seoyeon J. Lee, Ryan A. Peterson, Natalia A. Achtar-Zadeh, Francesco Boin, Paul J. Wolters, Joyce S. Lee

European Respiratory Journal Dec 2021, 58 (6) 2101560; DOI: 10.1183/13993003.01560-2021
Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
Pauline Henrot, Fabien Beaufils, Matthieu Thumerel, Edmée Eyraud, Augustin Boudoussier, Hugues Begueret, Elise Maurat, Pierre-Olivier Girodet, Roger Marthan, Patrick Berger, Isabelle Dupin, Maéva Zysman

European Respiratory Journal Dec 2021, 58 (6) 2101221; DOI: 10.1183/13993003.01221-2021
Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19
Elena A. Lapteva, Olga N. Kharevich, Victoria V. Khatsko, Natalia A. Voronova, Maksim V. Chamko, Irina V. Bezruchko, Elena I. Katibnikova, Elena I. Loban, Mostafa M. Mouawie, Helena Binetskaya, Sergey Aleshkevich, Aleksey Karankevich, Vitaly Dubinetski, Jørgen Vestbo, Alexander G. Mathioudakis

European Respiratory Journal Dec 2021, 58 (6) 2101907; DOI: 10.1183/13993003.01907-2021
Investigating the association between ALK receptor tyrosine kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database
Charles Khouri, Alex Hlavaty, Matthieu Roustit, Jean-Luc Cracowski, Marie-Camille Chaumais, Marc Humbert, David Montani

European Respiratory Journal Dec 2021, 58 (6) 2101576; DOI: 10.1183/13993003.01576-2021
Smoke-free vehicles: impact of legislation on child smoke exposure across three countries
Anthony A. Laverty, Filippos T. Filippidis, Jasper V. Been, Frances Campbell, Hazel Cheeseman, Nicholas S. Hopkinson

European Respiratory Journal Dec 2021, 58 (6) 2004600; DOI: 10.1183/13993003.04600-2020
Incidence and disease burden of coal workers’ pneumoconiosis worldwide, 1990–2019: evidence from the Global Burden of Disease Study 2019
Dongming Wang, Ruyi Liang, Meng Yang, Jixuan Ma, Wenzhen Li, Min Mu, Yang Xiao, Xiaobing Feng, Chaoqian Dong, Linling Yu, Wei Liu, Qiyou Tan, Min Zhou, Bin Wang, Tingming Shi, Liang Yuan, Weihong Chen

European Respiratory Journal Nov 2021, 58 (5) 2101669; DOI: 10.1183/13993003.01669-2021
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing
Kosuke Kato, Yoon-Joo Shin, Sunny Palumbo, Ioannis Papageorgiou, Seongmin Hahn, Joseph D. Irish, Skye P. Rounseville, Robert T. Krafty, Lutz Wollin, Maor Sauler, Louise Hecker

European Respiratory Journal Nov 2021, 58 (5) 2100759; DOI: 10.1183/13993003.00759-2021

Main menu

User menu

Search

More articles from Research letters

Pages

Contact us